A vaccine that could prevent - and even cure - brain cancer has been developed by scientists. The dual action therapy kills established tumours and trains the immune system to stop them recurring.
A gene-editing tool called CRISP-CAS9 releases proteins that primes them for destruction. In experiments, it worked on mice carrying cells derived from humans - mimicking what will happen in patients.
They had the deadliest form of brain cancer called glioblastoma. The US team described the results as "promising". Corresponding author Dr Khalid Shah, of Brigham and Women's Hospital in Boston, said: "Our team has pursued a simple idea: to take cancer cells and transform them into cancer killers and vaccines,.
